Interpretation of the 2020 American society of colon and rectal surgeons clinical practice guidelines for the management of rectal cancer.
10.3760/cma.j.cn.441530-20201218-00664
- Author:
Jian Ping WANG
1
Author Information
1. Department of Colorectal Surgery, the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, China.
- Publication Type:Journal Article
- Keywords:
Clinical practice guideline;
Multimodality therapy;
Rectal cancer;
Surgical procedures
- MeSH:
Humans;
Lymph Node Excision;
Neoplasms, Multiple Primary/therapy*;
Practice Guidelines as Topic;
Proctectomy;
Rectal Neoplasms/therapy*;
Rectum/surgery*;
United States
- From:
Chinese Journal of Gastrointestinal Surgery
2021;24(1):27-34
- CountryChina
- Language:Chinese
-
Abstract:
Located in the pelvic cavity and contiguous to the anal sphincter complex and urogenital organs, the rectum has more intricate anatomical features compared with the colon. Consequently, the treatment of rectal cancer involves more consideration, including pelvic radiation, lateral lymph node dissection, transanal access, postoperative function, sphincter preservation, and nonoperative management. Based on the last set of American society of colon and rectal surgeons (ASCRS) practice parameters for the management of rectal cancer published in 2013, the 2020 guidelines present evidence-based updates for both long-existing and emerging controversies on surgical management of rectal cancer. These updates include the indication for local resection, lymph node dissection for radical proctectomy, minimally invasive surgery, the "watch and wait" strategy for patients with clinical complete response, and prevention of anastomotic leak. Meanwhile, the guidelines recommend a risk-stratified approach for perioperative therapies for non-metastatic disease, and an individualized multimodality treatment based on treatment intent for synchronous metastatic disease.
